Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News AI-powered personalised medicine tool for hypertension being developed Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.
News Endovascular treatment more likely to avoid amputation or death for limb-threatening artery disease
News Dr Pavlovic to join the Council of European Section of the International Society for Heart Research
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
10 May 2023 AI-powered personalised medicine tool for hypertension being developed Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.
02 May 2023 Endovascular treatment more likely to avoid amputation or death for limb-threatening artery disease In the only randomised controlled trial of its kind, BASIL-2 enrolled 345 patients in 41 vascular surgery centres in UK, Sweden and Denmark
27 April 2023 ‘Vein-on-a-chip’ could help scientists study thrombosis without animal models Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies.
25 April 2023 Dr Pavlovic to join the Council of European Section of the International Society for Heart Research Dr Pavlovic has been elected to join a group of 12 distinguished European cardiovascular researchers from the International Society for Heart Research (ISHR).
09 March 2023 Naturally occurring peptide may tackle the ‘root cause’ of obesity-related conditions Research shows the peptide called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases
21 February 2023 Continue heart failure treatment despite initial kidney reduction, new guidelines suggest Summary of European Society of Cardiology report will direct both heart and kidney failure specialists to make best use of new treatments and prolong lives.
10 January 2023 Dr Pavlovic appointed as Editor in Chief of the Journal of Molecular and Cellular Cardiology PLUS JMCC PLUS publishes fundamental and translational research that advances knowledge of the mechanisms for normal and diseased cardiovascular function.